APN+: EU-India FTA being negotiated at the cost of patients lives
Friday, 10 February 2012
APN+ strongly condemns the EU’s deadly trade policies
10 February 2012, Bangkok – At the Annual General Meeting of the Asia Pacific Network of People Living with HIV (APN+), the APN+ Board strongly condemned the European Union’s continuing attacks on generic medicines through the EU-India FTA negotiations. At the EU-India Summit being held in New Delhi today, the EU is pressuring the Indian government to announce political “trade-offs” for the FTA negotiations.
“On the 3rd of February we took empty ARV bottles to the European Commission’s office to show them what the result of the EU-India FTA would be,” said Mr Sudin Sherchan of the National Association of People Living with HIV in Nepal. Since 2007, the EU-India FTA negotiations have become increasingly controversial as leaked texts of the negotiations show that the EU is pushing India to adopt intellectual property protection standards far in excess of what is required under the World Trade Organisation’s (WTO) Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS).


